The New Norway: “More Research And More Companies” – The Inven2 View
Plummeting oil prices prompted Norway’s politicians to look at developing other industries. As a result, several programs have been launched to incentivize new areas, including biopharma and diagnostics.
You may also be interested in...
Norwegian start-up CardiNor is developing a new cardiovascular biomarker, and is hopeful of attracting cash in a country where investor traditions are undergoing some changes. The financial pressures caused by falling oil prices have brought renewed attention to life science companies.
The UK has added important new capabilities to its COVID-19 monitoring and control effort and those running it promise a “world class system” by late summer.
The evolution of how and where patients receive their care has received an unexpected boost from the COVID-19 crisis. Coronavirus volume testing challenges persist, but the global medtech industry is now looking beyond the crisis toward a return to “normal” business.